AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,565 Cr | ₹2,387 Cr | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr |
What is the latest Revenue of AARTI DRUGS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,565 Cr |
| Mar2025 | ₹2,387 Cr |
| Mar2024 | ₹2,529 Cr |
| Mar2023 | ₹2,716 Cr |
| Mar2022 | ₹2,489 Cr |
How is Revenue of AARTI DRUGS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,565 Cr | 7.47 | |
| Mar2025 | ₹2,387 Cr | -5.60 | |
| Mar2024 | ₹2,529 Cr | -6.90 | |
| Mar2023 | ₹2,716 Cr | 9.14 | |
| Mar2022 | ₹2,489 Cr | - | |
Compare Revenue of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹4,559.1 Cr | -1.6% | 28.1% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -1.6% |
28.1% |
9.1% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses